Herpes Simplex Virus Infections Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Simplex Virus Infections Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 General Treatment
1.2.3 Antiviral Therapy
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus Infections Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Herpes Simplex Virus Infections Market Perspective (2017-2028)
2.2 Herpes Simplex Virus Infections Growth Trends by Region
2.2.1 Herpes Simplex Virus Infections Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Herpes Simplex Virus Infections Historic Market Size by Region (2017-2022)
2.2.3 Herpes Simplex Virus Infections Forecasted Market Size by Region (2023-2028)
2.3 Herpes Simplex Virus Infections Market Dynamics
2.3.1 Herpes Simplex Virus Infections Industry Trends
2.3.2 Herpes Simplex Virus Infections Market Drivers
2.3.3 Herpes Simplex Virus Infections Market Challenges
2.3.4 Herpes Simplex Virus Infections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Herpes Simplex Virus Infections Players by Revenue
3.1.1 Global Top Herpes Simplex Virus Infections Players by Revenue (2017-2022)
3.1.2 Global Herpes Simplex Virus Infections Revenue Market Share by Players (2017-2022)
3.2 Global Herpes Simplex Virus Infections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Herpes Simplex Virus Infections Revenue
3.4 Global Herpes Simplex Virus Infections Market Concentration Ratio
3.4.1 Global Herpes Simplex Virus Infections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infections Revenue in 2021
3.5 Herpes Simplex Virus Infections Key Players Head office and Area Served
3.6 Key Players Herpes Simplex Virus Infections Product Solution and Service
3.7 Date of Enter into Herpes Simplex Virus Infections Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Simplex Virus Infections Breakdown Data by Type
4.1 Global Herpes Simplex Virus Infections Historic Market Size by Type (2017-2022)
4.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2023-2028)
5 Herpes Simplex Virus Infections Breakdown Data by Application
5.1 Global Herpes Simplex Virus Infections Historic Market Size by Application (2017-2022)
5.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Herpes Simplex Virus Infections Market Size (2017-2028)
6.2 North America Herpes Simplex Virus Infections Market Size by Type
6.2.1 North America Herpes Simplex Virus Infections Market Size by Type (2017-2022)
6.2.2 North America Herpes Simplex Virus Infections Market Size by Type (2023-2028)
6.2.3 North America Herpes Simplex Virus Infections Market Share by Type (2017-2028)
6.3 North America Herpes Simplex Virus Infections Market Size by Application
6.3.1 North America Herpes Simplex Virus Infections Market Size by Application (2017-2022)
6.3.2 North America Herpes Simplex Virus Infections Market Size by Application (2023-2028)
6.3.3 North America Herpes Simplex Virus Infections Market Share by Application (2017-2028)
6.4 North America Herpes Simplex Virus Infections Market Size by Country
6.4.1 North America Herpes Simplex Virus Infections Market Size by Country (2017-2022)
6.4.2 North America Herpes Simplex Virus Infections Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Herpes Simplex Virus Infections Market Size (2017-2028)
7.2 Europe Herpes Simplex Virus Infections Market Size by Type
7.2.1 Europe Herpes Simplex Virus Infections Market Size by Type (2017-2022)
7.2.2 Europe Herpes Simplex Virus Infections Market Size by Type (2023-2028)
7.2.3 Europe Herpes Simplex Virus Infections Market Share by Type (2017-2028)
7.3 Europe Herpes Simplex Virus Infections Market Size by Application
7.3.1 Europe Herpes Simplex Virus Infections Market Size by Application (2017-2022)
7.3.2 Europe Herpes Simplex Virus Infections Market Size by Application (2023-2028)
7.3.3 Europe Herpes Simplex Virus Infections Market Share by Application (2017-2028)
7.4 Europe Herpes Simplex Virus Infections Market Size by Country
7.4.1 Europe Herpes Simplex Virus Infections Market Size by Country (2017-2022)
7.4.2 Europe Herpes Simplex Virus Infections Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Herpes Simplex Virus Infections Market Size (2017-2028)
8.2 Asia-Pacific Herpes Simplex Virus Infections Market Size by Type
8.2.1 Asia-Pacific Herpes Simplex Virus Infections Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Herpes Simplex Virus Infections Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Herpes Simplex Virus Infections Market Share by Type (2017-2028)
8.3 Asia-Pacific Herpes Simplex Virus Infections Market Size by Application
8.3.1 Asia-Pacific Herpes Simplex Virus Infections Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Herpes Simplex Virus Infections Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Herpes Simplex Virus Infections Market Share by Application (2017-2028)
8.4 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region
8.4.1 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Herpes Simplex Virus Infections Market Size (2017-2028)
9.2 Latin America Herpes Simplex Virus Infections Market Size by Type
9.2.1 Latin America Herpes Simplex Virus Infections Market Size by Type (2017-2022)
9.2.2 Latin America Herpes Simplex Virus Infections Market Size by Type (2023-2028)
9.2.3 Latin America Herpes Simplex Virus Infections Market Share by Type (2017-2028)
9.3 Latin America Herpes Simplex Virus Infections Market Size by Application
9.3.1 Latin America Herpes Simplex Virus Infections Market Size by Application (2017-2022)
9.3.2 Latin America Herpes Simplex Virus Infections Market Size by Application (2023-2028)
9.3.3 Latin America Herpes Simplex Virus Infections Market Share by Application (2017-2028)
9.4 Latin America Herpes Simplex Virus Infections Market Size by Country
9.4.1 Latin America Herpes Simplex Virus Infections Market Size by Country (2017-2022)
9.4.2 Latin America Herpes Simplex Virus Infections Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Herpes Simplex Virus Infections Market Size (2017-2028)
10.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Type
10.2.1 Middle East & Africa Herpes Simplex Virus Infections Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Herpes Simplex Virus Infections Market Share by Type (2017-2028)
10.3 Middle East & Africa Herpes Simplex Virus Infections Market Size by Application
10.3.1 Middle East & Africa Herpes Simplex Virus Infections Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Herpes Simplex Virus Infections Market Share by Application (2017-2028)
10.4 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country
10.4.1 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Admedus Limited
11.1.1 Admedus Limited Company Details
11.1.2 Admedus Limited Business Overview
11.1.3 Admedus Limited Herpes Simplex Virus Infections Introduction
11.1.4 Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.1.5 Admedus Limited Recent Developments
11.2 Agenus Inc.
11.2.1 Agenus Inc. Company Details
11.2.2 Agenus Inc. Business Overview
11.2.3 Agenus Inc. Herpes Simplex Virus Infections Introduction
11.2.4 Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.2.5 Agenus Inc. Recent Developments
11.3 Aicuris Anti-infective Cures Gmbh
11.3.1 Aicuris Anti-infective Cures Gmbh Company Details
11.3.2 Aicuris Anti-infective Cures Gmbh Business Overview
11.3.3 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Introduction
11.3.4 Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.3.5 Aicuris Anti-infective Cures Gmbh Recent Developments
11.4 Asahi Kasei Corporation
11.4.1 Asahi Kasei Corporation Company Details
11.4.2 Asahi Kasei Corporation Business Overview
11.4.3 Asahi Kasei Corporation Herpes Simplex Virus Infections Introduction
11.4.4 Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.4.5 Asahi Kasei Corporation Recent Developments
11.5 Chimerix Inc.
11.5.1 Chimerix Inc. Company Details
11.5.2 Chimerix Inc. Business Overview
11.5.3 Chimerix Inc. Herpes Simplex Virus Infections Introduction
11.5.4 Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.5.5 Chimerix Inc. Recent Developments
11.6 Clinigen Group Plc
11.6.1 Clinigen Group Plc Company Details
11.6.2 Clinigen Group Plc Business Overview
11.6.3 Clinigen Group Plc Herpes Simplex Virus Infections Introduction
11.6.4 Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.6.5 Clinigen Group Plc Recent Developments
11.7 Daewoong Pharmaceutical Co., Ltd.
11.7.1 Daewoong Pharmaceutical Co., Ltd. Company Details
11.7.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
11.7.3 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Introduction
11.7.4 Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.7.5 Daewoong Pharmaceutical Co., Ltd. Recent Developments
11.8 F. Hoffmann-la Roche Ltd.
11.8.1 F. Hoffmann-la Roche Ltd. Company Details
11.8.2 F. Hoffmann-la Roche Ltd. Business Overview
11.8.3 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Introduction
11.8.4 F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.8.5 F. Hoffmann-la Roche Ltd. Recent Developments
11.9 Glaxosmithkline Plc
11.9.1 Glaxosmithkline Plc Company Details
11.9.2 Glaxosmithkline Plc Business Overview
11.9.3 Glaxosmithkline Plc Herpes Simplex Virus Infections Introduction
11.9.4 Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.9.5 Glaxosmithkline Plc Recent Developments
11.10 Maruho Co. Ltd.
11.10.1 Maruho Co. Ltd. Company Details
11.10.2 Maruho Co. Ltd. Business Overview
11.10.3 Maruho Co. Ltd. Herpes Simplex Virus Infections Introduction
11.10.4 Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.10.5 Maruho Co. Ltd. Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Herpes Simplex Virus Infections Introduction
11.11.4 Merck Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.11.5 Merck Recent Developments
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Herpes Simplex Virus Infections Introduction
11.12.4 Mylan Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.12.5 Mylan Recent Developments
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Herpes Simplex Virus Infections Introduction
11.13.4 Novartis Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.13.5 Novartis Recent Developments
11.14 Sanofi Pasteur
11.14.1 Sanofi Pasteur Company Details
11.14.2 Sanofi Pasteur Business Overview
11.14.3 Sanofi Pasteur Herpes Simplex Virus Infections Introduction
11.14.4 Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.14.5 Sanofi Pasteur Recent Developments
11.15 Teva Pharmaceutical Industries Ltd.
11.15.1 Teva Pharmaceutical Industries Ltd. Company Details
11.15.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.15.3 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Introduction
11.15.4 Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Herpes Simplex Virus Infections Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of General Treatment
Table 3. Key Players of Antiviral Therapy
Table 4. Global Herpes Simplex Virus Infections Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Herpes Simplex Virus Infections Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Herpes Simplex Virus Infections Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Herpes Simplex Virus Infections Market Share by Region (2017-2022)
Table 8. Global Herpes Simplex Virus Infections Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Herpes Simplex Virus Infections Market Share by Region (2023-2028)
Table 10. Herpes Simplex Virus Infections Market Trends
Table 11. Herpes Simplex Virus Infections Market Drivers
Table 12. Herpes Simplex Virus Infections Market Challenges
Table 13. Herpes Simplex Virus Infections Market Restraints
Table 14. Global Herpes Simplex Virus Infections Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Herpes Simplex Virus Infections Revenue Share by Players (2017-2022)
Table 16. Global Top Herpes Simplex Virus Infections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infections as of 2021)
Table 17. Ranking of Global Top Herpes Simplex Virus Infections Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Herpes Simplex Virus Infections Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Herpes Simplex Virus Infections Product Solution and Service
Table 21. Date of Enter into Herpes Simplex Virus Infections Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Herpes Simplex Virus Infections Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Herpes Simplex Virus Infections Revenue Market Share by Type (2017-2022)
Table 25. Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Herpes Simplex Virus Infections Revenue Market Share by Type (2023-2028)
Table 27. Global Herpes Simplex Virus Infections Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Herpes Simplex Virus Infections Revenue Share by Application (2017-2022)
Table 29. Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Herpes Simplex Virus Infections Revenue Share by Application (2023-2028)
Table 31. North America Herpes Simplex Virus Infections Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Herpes Simplex Virus Infections Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Herpes Simplex Virus Infections Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Herpes Simplex Virus Infections Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Herpes Simplex Virus Infections Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Herpes Simplex Virus Infections Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Herpes Simplex Virus Infections Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Herpes Simplex Virus Infections Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Herpes Simplex Virus Infections Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Herpes Simplex Virus Infections Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Herpes Simplex Virus Infections Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Herpes Simplex Virus Infections Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Herpes Simplex Virus Infections Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Herpes Simplex Virus Infections Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Herpes Simplex Virus Infections Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Herpes Simplex Virus Infections Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Herpes Simplex Virus Infections Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Herpes Simplex Virus Infections Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Herpes Simplex Virus Infections Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Herpes Simplex Virus Infections Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Herpes Simplex Virus Infections Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Herpes Simplex Virus Infections Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Herpes Simplex Virus Infections Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Herpes Simplex Virus Infections Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Herpes Simplex Virus Infections Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Herpes Simplex Virus Infections Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Herpes Simplex Virus Infections Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Herpes Simplex Virus Infections Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Herpes Simplex Virus Infections Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Herpes Simplex Virus Infections Market Size by Country (2023-2028) & (US$ Million)
Table 61. Admedus Limited Company Details
Table 62. Admedus Limited Business Overview
Table 63. Admedus Limited Herpes Simplex Virus Infections Product
Table 64. Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 65. Admedus Limited Recent Developments
Table 66. Agenus Inc. Company Details
Table 67. Agenus Inc. Business Overview
Table 68. Agenus Inc. Herpes Simplex Virus Infections Product
Table 69. Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 70. Agenus Inc. Recent Developments
Table 71. Aicuris Anti-infective Cures Gmbh Company Details
Table 72. Aicuris Anti-infective Cures Gmbh Business Overview
Table 73. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product
Table 74. Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 75. Aicuris Anti-infective Cures Gmbh Recent Developments
Table 76. Asahi Kasei Corporation Company Details
Table 77. Asahi Kasei Corporation Business Overview
Table 78. Asahi Kasei Corporation Herpes Simplex Virus Infections Product
Table 79. Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 80. Asahi Kasei Corporation Recent Developments
Table 81. Chimerix Inc. Company Details
Table 82. Chimerix Inc. Business Overview
Table 83. Chimerix Inc. Herpes Simplex Virus Infections Product
Table 84. Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 85. Chimerix Inc. Recent Developments
Table 86. Clinigen Group Plc Company Details
Table 87. Clinigen Group Plc Business Overview
Table 88. Clinigen Group Plc Herpes Simplex Virus Infections Product
Table 89. Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 90. Clinigen Group Plc Recent Developments
Table 91. Daewoong Pharmaceutical Co., Ltd. Company Details
Table 92. Daewoong Pharmaceutical Co., Ltd. Business Overview
Table 93. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product
Table 94. Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 95. Daewoong Pharmaceutical Co., Ltd. Recent Developments
Table 96. F. Hoffmann-la Roche Ltd. Company Details
Table 97. F. Hoffmann-la Roche Ltd. Business Overview
Table 98. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product
Table 99. F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 100. F. Hoffmann-la Roche Ltd. Recent Developments
Table 101. Glaxosmithkline Plc Company Details
Table 102. Glaxosmithkline Plc Business Overview
Table 103. Glaxosmithkline Plc Herpes Simplex Virus Infections Product
Table 104. Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 105. Glaxosmithkline Plc Recent Developments
Table 106. Maruho Co. Ltd. Company Details
Table 107. Maruho Co. Ltd. Business Overview
Table 108. Maruho Co. Ltd. Herpes Simplex Virus Infections Product
Table 109. Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 110. Maruho Co. Ltd. Recent Developments
Table 111. Merck Company Details
Table 112. Merck Business Overview
Table 113. Merck Herpes Simplex Virus Infections Product
Table 114. Merck Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 115. Merck Recent Developments
Table 116. Mylan Company Details
Table 117. Mylan Business Overview
Table 118. Mylan Herpes Simplex Virus Infections Product
Table 119. Mylan Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 120. Mylan Recent Developments
Table 121. Novartis Company Details
Table 122. Novartis Business Overview
Table 123. Novartis Herpes Simplex Virus Infections Product
Table 124. Novartis Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 125. Novartis Recent Developments
Table 126. Sanofi Pasteur Company Details
Table 127. Sanofi Pasteur Business Overview
Table 128. Sanofi Pasteur Herpes Simplex Virus Infections Product
Table 129. Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 130. Sanofi Pasteur Recent Developments
Table 131. Teva Pharmaceutical Industries Ltd. Company Details
Table 132. Teva Pharmaceutical Industries Ltd. Business Overview
Table 133. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product
Table 134. Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022) & (US$ Million)
Table 135. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Simplex Virus Infections Market Share by Type: 2021 VS 2028
Figure 2. General Treatment Features
Figure 3. Antiviral Therapy Features
Figure 4. Global Herpes Simplex Virus Infections Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Herpes Simplex Virus Infections Report Years Considered
Figure 9. Global Herpes Simplex Virus Infections Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Herpes Simplex Virus Infections Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Herpes Simplex Virus Infections Market Share by Region: 2021 VS 2028
Figure 12. Global Herpes Simplex Virus Infections Market Share by Players in 2021
Figure 13. Global Top Herpes Simplex Virus Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infections as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Herpes Simplex Virus Infections Revenue in 2021
Figure 15. North America Herpes Simplex Virus Infections Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Herpes Simplex Virus Infections Market Size Market Share by Type (2017-2028)
Figure 17. North America Herpes Simplex Virus Infections Market Size Market Share by Application (2017-2028)
Figure 18. North America Herpes Simplex Virus Infections Market Size Share by Country (2017-2028)
Figure 19. United States Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Herpes Simplex Virus Infections Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Herpes Simplex Virus Infections Market Size Market Share by Type (2017-2028)
Figure 23. Europe Herpes Simplex Virus Infections Market Size Market Share by Application (2017-2028)
Figure 24. Europe Herpes Simplex Virus Infections Market Size Share by Country (2017-2028)
Figure 25. Germany Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Herpes Simplex Virus Infections Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Herpes Simplex Virus Infections Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Herpes Simplex Virus Infections Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Herpes Simplex Virus Infections Market Size Share by Region (2017-2028)
Figure 35. China Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Herpes Simplex Virus Infections Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Herpes Simplex Virus Infections Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Herpes Simplex Virus Infections Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Herpes Simplex Virus Infections Market Size Share by Country (2017-2028)
Figure 45. Mexico Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Herpes Simplex Virus Infections Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Herpes Simplex Virus Infections Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Herpes Simplex Virus Infections Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Herpes Simplex Virus Infections Market Size Share by Country (2017-2028)
Figure 51. Turkey Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Herpes Simplex Virus Infections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Admedus Limited Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 55. Agenus Inc. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 56. Aicuris Anti-infective Cures Gmbh Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 57. Asahi Kasei Corporation Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 58. Chimerix Inc. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 59. Clinigen Group Plc Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 60. Daewoong Pharmaceutical Co., Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 61. F. Hoffmann-la Roche Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 62. Glaxosmithkline Plc Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 63. Maruho Co. Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 65. Mylan Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 66. Novartis Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 67. Sanofi Pasteur Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 68. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Industry Market Size
